Autor: "Thress KS" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report.
Autorzy:: Chen S; Department of Human and Animal Cell Lines, DSMZ - German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7b, 38124, Braunschweig, Germany.; Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Nagel S; Department of Human and Animal Cell Lines, DSMZ - German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7b, 38124, Braunschweig, Germany.
Schneider B; Department of Human and Animal Cell Lines, DSMZ - German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7b, 38124, Braunschweig, Germany.; Institute of Pathology and Molecular Pathology, University of Rostock, Rostock, Germany.
Dai H; Department of Human and Animal Cell Lines, DSMZ - German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7b, 38124, Braunschweig, Germany.; Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
Geffers R; Genome Analytics Research Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Kaufmann M; Department of Human and Animal Cell Lines, DSMZ - German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7b, 38124, Braunschweig, Germany.
Meyer C; Department of Human and Animal Cell Lines, DSMZ - German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7b, 38124, Braunschweig, Germany.
Pommerenke C; Department of Human and Animal Cell Lines, DSMZ - German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7b, 38124, Braunschweig, Germany.
Thress KS; AstraZeneca Oncology Innovative Medicines, Waltham, MA, USA.
Li J; Department of Hematology, Yixing People's Hospital of Jiangsu Province, Yixing, People's Republic of China.
Quentmeier H; Department of Human and Animal Cell Lines, DSMZ - German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7b, 38124, Braunschweig, Germany.
Drexler HG; Department of Human and Animal Cell Lines, DSMZ - German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7b, 38124, Braunschweig, Germany.
MacLeod RAF; Department of Human and Animal Cell Lines, DSMZ - German Collection of Microorganisms and Cell Cultures, Inhoffenstrasse 7b, 38124, Braunschweig, Germany. .; Pokaż więcej
Źródło:: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2018 Feb; Vol. 41 (1), pp. 93-101. Date of Electronic Publication: 2017 Nov 08.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Promyelocytic, Acute/*genetics
Oncogene Proteins, Fusion/*genetics
RNA, Long Noncoding/*metabolism
Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Arsenic Trioxide ; Arsenicals/pharmacology ; Arsenicals/therapeutic use ; Cell Line ; Cell Proliferation/drug effects ; Humans ; Leukemia, Promyelocytic, Acute/drug therapy ; Leukemia, Promyelocytic, Acute/metabolism ; Leukemia, Promyelocytic, Acute/pathology ; Mitogen-Activated Protein Kinase 1/metabolism ; Models, Biological ; Oxides/pharmacology ; Oxides/therapeutic use ; Pyrimidines/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.
Autorzy:: Thress KS; AstraZeneca, Gatehouse Park, Waltham, Massachusetts, USA.
Paweletz CP; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Felip E; 1] Vall d'Hebron Institute of Oncology, Barcelona, Spain. [2] Vall d'Hebron University Hospital, Barcelona, Spain.
Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Stetson D; AstraZeneca, Gatehouse Park, Waltham, Massachusetts, USA.
Dougherty B; AstraZeneca, Gatehouse Park, Waltham, Massachusetts, USA.
Lai Z; AstraZeneca, Gatehouse Park, Waltham, Massachusetts, USA.
Markovets A; AstraZeneca, Gatehouse Park, Waltham, Massachusetts, USA.
Vivancos A; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Kuang Y; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Ercan D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Matthews SE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Cantarini M; AstraZeneca, Alderley Park, Macclesfield, UK.
Barrett JC; AstraZeneca, Gatehouse Park, Waltham, Massachusetts, USA.
Jänne PA; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Oxnard GR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Pokaż więcej
Źródło:: Nature medicine [Nat Med] 2015 Jun; Vol. 21 (6), pp. 560-2. Date of Electronic Publication: 2015 May 04.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Acrylamides/*administration & dosage
Aniline Compounds/*administration & dosage
Carcinoma, Non-Small-Cell Lung/*drug therapy
ErbB Receptors/*genetics
Adult ; Aged ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/pathology ; Drug Resistance, Neoplasm ; Female ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Middle Aged ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Thress KS"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język